Çiler ZİNCİRCİOĞLU, Hüseyin ÖZKARAKAŞ, Aykut SARITAŞ, Gürsel ERSAN, Kazım ROLLAS, Nimet ŞENOĞLU, Işıl Köse GÜLDOĞAN

Diagnostic value of procalcitonin and C reactive protein for infection and sepsis in elderly patients

Background/aim: Biomarkers are useful for diagnosing infection and sepsis in adults, but data are limited in elderly patients. Furthermore, clinical symptoms of infection in elderly patients are usually atypical or unclear. We aimed to assess the usefulness of PCT, CRP, and WBC in distinguishing elderly patients infected with sepsis from infected without sepsis and those with no-infection. We also aimed to find a cut-off value for diagnosing sepsis and infection without sepsis in elderly critically ill patients. Materials and methods: In this single-center and prospective observational study, patients older than 65 years were enrolled. Serum levels of PCT, CRP, and WBC were measured within 24 h. Patients were allocated into sepsis (S), infected without sepsis (IWS), and noinfection (NI) groups. Data were analyzed with Mann–Whitney U test and Kruskal–Wallis test. Results: We analyzed 188 patients with a mean age of 77.05 ± 7.4 in the study; 95 (50.5%) of them were women. Sixty-four (34%) of whom were classified as IWS, 29 (15%) as S, and 95 (50.5%) as NI group. There were significant differences in the PCT, CRP levels between the IWS and NI, S and NI (p < 0.001, p < 0.001, p < 0.001, p < 0.01, respectively). The PCT levels were significantly different when the NI group was compared to IWS (p < 0.001) and S (p < 0.001) groups. The CRP levels were also different when the NI group was compared to both IWS (p < 0.001) and S (p < 0.001). The PCT cut-off values were 0.485 μ/L and 1.245 μg/L for the discrimination of patients with IWS and S, respectively. The cut-off values of CRP level were 59.45 mg/L and 57.50 mg/L for infected without sepsis and sepsis, respectively.Conclusion: PCT was found to be a more valuable marker than CRP and WBC for the discrimination of elderly patients with infected without sepsis and sepsis. Key words: Aged, procalcitonin, C-reactive protein, infections, sepsis

PDF

___

1. Flaatten H, De Lange DW, Artigas A, Bin D, Moreno R et al. The status of intensive care medicine research and a future agenda for very old patients in the ICU. Intensive Care Medicine 2017; 43 (9): 1319-1328. doi: 10.1007/s00134-017-4718-z
2. Heppner HJ, Sieber C, Walger P, Bahrmann P, Singler K. Infections in the elderly. Critical Care Clinics 2013; 29 (3): 757- 774. doi: 10.1016/j.ccc.2013.03.016
3. Opal SM, Girard TD, Ely EW. The immunopathogenesis of sepsis in elderly patients. Clinical Infectious Diseases 2005; 41 (7): 504–512. doi: 10.1086/432007
4. Van Duin D. Diagnostic challenges and opportunities in older adults with infectious diseases. Clinical Infectious Diseases 2012; 54 (7): 973–978. doi: 10.1093/cid/cir92
5. Bassettı M, Montero JG, Paıva JA. When antibiotic treatment fails. Intensive Care Medicine 2018; 44 (1): 73-75. doi: 10.1007/ s00134-017-4962-2
6. Bassettı M, Alessandro R, Elda R, Elisabetta D, Maria M et al. Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology. Expert Review of Anti-infective Therapy 2019; 17 (2): 99-105. doi: 10.1080/14787210.2019.1562335
7. Hoeboer SH, Geestet JV, Nieboer D, Groeneveld ABJ. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clinical Microbiology and Infection 2015; 21 (5): 474-481. doi: 10.1016/j.cmi.2014.12.026
8. Tan M, Lu Y, Jiang H, Zhang L. The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis. Journal of Cellular Biochemistry 2019; 120 (4): 5852-5859. doi: 10.1002/jcb.27870
9. Lee SH, Chan RC, Wu JY, Chen HW, Chang SS et al. Diagnostic value of procalcitonin for bacterial infection in elderly patients - a systematic review and meta-analysis. International Journal of Clinical Practice 2013; 67 (12): 1350-1357. doi: 10.1111/ ijcp.12278
10. Steichen O, Bouvard E, Grateau G, Bailleul S, Capeau J et al. Diagnostic value of procalcitonin in acutely hospitalized elderly patients. European Journal of Clinical Microbiology & Infectious Diseases 2009; 28 (12): 1471–1476. doi: 10.1007/ s10096-009-0807-4
11. Ticinesi A, Lauretani F, Nouvenne A, Porro E, Fanelli G et al. C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute infection. European Journal of Internal Medicine 2017; 37 (1): 7–12. doi: 10.1016/j.ejim.2016.08.026
12. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock. Critical Care Medicine 2017; 45 (3): 486–552. doi: 10.1097/CCM.0000000000002255
13. Chakhtoura NG, Bonomo RA, Jump RLP. Influence of aging and environment on presentation of infection in older adults. Infectious Disease Clinics of North America 2017; 31 (4): 593- 608. doi: 10.1016/j.idc.2017.07.017
14. Boenısch S, Fae P, Drexel H, Walli AK, Fraunberger P. Are circulating levels of CRP compared to IL-6 and PCT still relevant in intensive care unit patients? Journal of Laboratory Medicine 2013; 37 (1) 1-10. https://doi.org/10.1515/ labmed-2013-0029
15. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive care medicine 2000; 26 (2): 148-152. doi: 10.1007/BF02900728
16. Meynaar IA, Droog W, Batstra M, Vreede R, Herbrink P. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Critical Care Research and Practice 2011; 2011 (5): 594- 645. doi: 10.1155/2011/594645
17. Lin W, Huang H, Wen J, Chen G, Lin X et al. The predictive value of procalcitonin for early detection of infection in elderly type 2 diabetes mellitus. Journal of Infection and Chemotherapy 2020; 26 (4): 343-348. doi: 10.1016/j.jiac.2019.10.015
18. Nouvenne A, Ticinesi A, Folesani G, Cerundolo N, Prati B et al. The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort study. BMC Geriatrics 2016; (16): 2-8 doi: 10.1186/s12877-016-0192-7
19. Mahshid TT, Babazadeh S, Barati M, Latifnia M. Serum inflammatory markers in the elderly: are they useful in differentiating sepsis from SIRS?.Acta Medica Iranica 2014; 52 (6): 438-442.
20. Stucker F, Herrmann F, Graf JD, Michel JP, Krause KH et al. Procalcitonin and infection in elderly patients. Journal of the American Geriatrics Society. Journal of American Geriatrics Society 2005; 53 (8): 1392–1395. doi: 10.1111/j.1532- 5415.2005.53421.x
21. Zhang H, Wang X, Zhang Q, Xia Y, Liu D. Comparison of procalcitonin and high-sensitivity C-reactive protein for the diagnosis of sepsis and septic shock in the oldest old patients. BMC Geriatrics 2017; 17 (1): 2-8. doi: 10.1186/s12877-017- 0566-5
22. Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infectious Diseases 2013; 13 (5): 426-435. doi: 10.1016/S1473-3099(12)70323-7
23. Caterino JM, Scheatzle MD, Forbes ML, D’Antonio JA. Bacteremic elder emergency department patients: procalcitonin and white count. Academic Emergency Medicine 2004; 11 (4): 393–396. doi: 10.1197/j.aem.2003.10.027
24. Liu A, Bui T, Nguyen HV, Ong B, Shen Q et al. Serum C-reactive protein as a biomarker for early detection of bacterial infection in the older patient. Age Ageing 2010; 39 (5): 559–565. doi: 10.1093/ageing/afq067
25. Romano AD, Buglio AL, Bellanti F, Villani R, Serviddio G et al. Diagnostic reliability of the procalcitonin serum marker in septic frail patient. Aging Clinical and Experimental Research 2019; 31 (5): 727-732. doi: 10.1007/s40520-018-1020-z
26. Level C, Chauveau P, Delmas Y, Lasseur C, Pellé G et al. Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrology Dialysis Transplantation 2001; 16 (5): 980-986. doi: 10.1093/ndt/16.5.980
27. Abdulkader RC, Burdmann EA, Lebrao ML, Duarte YAO. Aging and decreased glomerular filtration rate: An elderly population-based study. PloS One 2017; 12 (12) e0189935. doi: 10.1371/journal.pone.0189935
28. Chenevier GC, Trabattoni E, Elfassy Y, Picard C, Guerin S et al. Decisional procalcitonin thresholds are not adapted to elderly patients admitted to the emergency room. Biomarkers 2012; 17 (5): 477-481. doi: 10.3109/1354750X.2012.685953
29. Gbinigie OA, Onakpoya IJ, Richards GC, Spencer EA, Koshiaris C et al. Biomarkers for diagnosing serious bacterial infections in older outpatients: a systematic review. BMC Geriatrics 2019; 19 (1): 190. doi: 10.1186/s12877-019-1205-0